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day 2. In 58 pts without known prior hyperlipidemia, 59% were tested during
admission (vs. ss~o, p = NS); and 17% (vs. 17%, p = NS) had fasting panele
by hospital day 2. Of tested pts who met criteria for treatment (n = 34), 35%
received therapy at discharge. Cone/uSiOrI.’An intensive physician education
program can significantly improve compliance with current guidelines for lipid
teeting but therapy remains suboptimal.
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D R,*922149 Lunchables@Increase Blood Praasure in Dahl
R.L. Pez, J.L. Osbom, C.E. Grim. Physiology&Inter.Med.,MedicalCoil.of
Wis., Milwaukee,USA
Human populations ingesting more than 80 mM NsJday(1 mM Nsdkgbody
wt) demonstrate an increaee in blood pressure (BP) with age resulting in pre-
mature death and disability. Lunchables” (L), a snack marketed to children,
contains 1780 mg “sodium (77.4 mM Na) which is 2.2 mM Ne/kg for a 35
kg child. The cumulative effects of L on BP in Dahl Salt Sensitive (S) Rats
were tested by feeding ad Iibiturrrground up food for 22 days beginning at
12 weeks of age to Dahl S rats initially raised on a 0.4% Na diet. Rats were
separated into 3 diet groups (4 rats each). Low (0.4% Na): composed of low
Na rat chow, Medium (0.75Y. Na): a ground up diet of items purchased to
eimulate a lower Na L, and High (1.5% Na): aground up diet composed of L.
After 22 daye intraarterial BP was measured in conscious rata over 3 days.
Data were analyzed (table) by repeated measures analysis of variance: *p
<0.05 vs Low Na.
922-151 Alterations of Left Ventricular Geometry and
Function in Subjects with White Coat
Hypertension
M. Muscholl, H.W. Hense, U. Brockel, A. Doring, U. Keil, G.A. Riegger,
H. Schunkert. Universitiesof FfegensLwrgandkftinstecGemrany
The prevalence of white coat hypertension (WCHT) in the general population
and its relationship to left ventricular hypertrophy (LVH) and alterations of
LV function is still unclear. To investigate this issue, we studied 1677 aub-
jects of a population based cohort (WI-IOMONICA-Projekt, Augeburg). Blood
presaure readings were performed in a sitting position according to a stan-
dardized protocol both during a 60 minutes period of relaxed conversation
and filling out questionnaires(BP-T, mean of second and third measurement
by a technician) and after echocerdiography (BP-MD, by a physician). Sub-
jects were characterized as normotensive (NT; BP-T and BP-MD c 140/90
mmHg, n = 849), mildly hypertensive (MHT; BP-T > 140/90 and BP-MD <
160/95 mmHg, n = 129), white coat hypertensive (WCHT; BP-T < 140/90,
BP-MD > 160/95 mmHg, n = 160), and hypertensive (HTN; antihypertensive
medication or SP-T > 140/90 and BP-MD > 160/95 mmHg, n = 538). WCHT
were younger (51 years) than MHT and HTN (55 and 61 years), however
more obese (28 kg/m2) than NT and MHT (25 and 26.5 k@m2; p <0.05
each). Systolic meridional wallstress as well as the prevalence of LVH (Penn
mass; g/m) were markedly increased in WCHT (75 dynes/cm2; LVH 32%)
and HTN (76 dynes/cm2; LVH 57~o) compared to NT (68 dynee/cm2; LVH
12%) and MHT (71 dynee/cm2; LVH 19%), p <0.05 each. Systolic function
was normal, however, Doppler diastolic filling paraineters were markedly al-
tered in WCHT, MHT,and HTN (krtE/A 1.9, 1.7, and 1.4; IVRT79, 80, and 89
ms) compared to NT (lntE/A 2.3, IVRT 74 ms, p < 0.05). Finally, multivariate
analysis revealed that WCHTwas a predictor of increased LV mass indepen-
dent of body mass index, sex, and age. However, an independent impact of
WCHT on diastolic filling was not detected. Thus, in the general population
a large group of aubjects with normal blood pressure ie at increased risk for
LVHdue to exaggerated blood pressure response to mild stress.
DietNa MAP(mmHg) HearlWt(gin) KidneyWt(gin)
Low 133&4.2 1.20+0.03 2.6ei 0.10 -[ The Relative Value OfpharmaCo@icalStreSe
Medium 146*4.6* 1.35+0.05” 2,92*O.1O Echo and Exercise Streas Testing for Riak
High 159l3.e* 1.41+0.02’ 3.36+ 0.19* Stratification in Hypettenaives
LeuroCortigiani,EmilioA. Paolini,AndreaBoni,PietroGaddi,
Thechildren’ssnack,L,andevena dietwith50%less Na, increasedblood EugenioNannini. CardiovascularUnit,CastekruovoGarfagnanaHospital,
cmessure,and inducxxl cardiac end renal hypertrophy in this salt sensitive Lucca, Italv
genotype. A Na induced increase in BP in any salt sensitive phenotype will
reeult in detrimental effects including cardiac hypertrophy and renal damage. To assess the relative prognostic value of dipyridamole-atropine stress echo
Children and adulte from aalt sensitive families and ethnic groups, should (DASE) (0.64 mg/kg over 10’ + atropine up to 1 mg during 2-D echo and
avoid these and other high Nasnacks. Warningsof the toxic effectsof sodium 12-lead ECG monitoring) and bicycla exercise electrocardiography testing
in many people should be placed on these dangerous snacks. (EET) (incremental workloads of 25 W every 2’) in hypertension, thetwotests
were performed in 169 hyperfeneive patients (pts) (age 61 + 8 yeare; mean
+ SD) with known orsusoected coronary artery diaease. No patient had a left
D ~,angea,922150 Does Gander Influanca Diuratic Induced Lipid
P.Narayan, V. Papademetriou. Dept.of VeteransAffairsandGeorgetown
UniversityMedicalCenters,Washington,DC,USA
The purpoee of the study was to asSess the effect of diuretic therapy on
lipid changes in male and female patients with hypertension. Several etudies
have shown mild and transient increase in LDL-cholesterol and triglycerides
(Trig) with diuretic therapy but mostly in hypertensive men. Data in female
hypertensivea is scarce.In this study 61 males (age = 55 t 13 years) and
24 females (age = 59 l 8 yeare) with essential hypertension were treated
with hydrochlorothiazide (HCTZ; average doae 42.5 mg daily). Both groups
were followed for 6 months (m) with comparable diastolic BP reduction. Lipid
changeswithingroupsfrom baseline to3mand6m, in mg/dL,were asfollows:
Males Females
3m P 6m P 3m P 6m P
Chol 10*21 0.002 6*25 0.1s 1S+ 27 0.02 19i 20 0.002
LDL 4*19 0.2 1&24 0.s7 17+ 27 0.01 21l21 0002
Trig 35+6S 0,001 27+ 106 0.13 14+ 69 0.40 5l49 0.73
HDL 0.3&s 0,s2 0.2*7 0.S6 –1 %s 0.50 -3*7 0.1s
p= pvslue
Unlike malee, in hypertensive females, LDL-cholesterol and total choles-
terol levels were sustained higher than baseline after 6 months of HCTZ
but triglycerides did not rise significantly at 3 or 6 months. In males triglyc-
erides and total cholesterol rose significantly at 3 months but decreased at 6
months. HDL-cholesterol Ievaledid not change in either group.
Cone/usion:Lipid changes with diuretic therapy are more pronounced and
longer lasting in hypertensive women as compared to hypertensive men.
bundle branch block at baseline ECG, was taking digitalie or antiarrhythmic
medications. The only criterion for DASE positivity was the appearance of
new functional abnormalities during test. ECG criterion of positivity during
EET was an ST-segment shift >0.1 mV from baseline 80 msec after the J
point in at least two contiguous leads. DASE was positive in 46 pts. EET
was positive in 61 pts, 29 of whom had also a DASE positivity. During the
follow-up (31 +18 months) 36 cardiac events occurred: 3 deaths, 4 nonfatal
infarctions, 10 unstable angina and 19 coronary revascularizations. The
positive predictive value was higher for DASE compared with EET (54 vs.
35%; p s 0.05). It rose to 697. in pts having both DASE and EET positivity.
The negative predictive value was 91% for DASE and 877. for EET (p = NS).
Pharmacological stress echo is more efficient than exercise electrocar-
diography testing for diagnostic purposes in hypertensive, but to date their
relative prognostic values remain unknown. Our results show that DASE is
more efficient than EET in risk stratification of hypertensive. However, a
simple negative EET is sufficient to identify a very low risk subset in whom
additional testing may not be warranted.
~922-1531 lnadaquateHigh B1OOdpreOauraAwarene*e and
Control Using National Treatment Guidalinea in a
Population With Multiple Risk Factors
L.R. Yanek, B.G. Kral, T.F.Moy, J.V. Raqueno, D.M. Becker. JohnsHopkins
MedicalInstitutions,Ba/tinrore,MD,uSA
The NIH National Commifteeon Detection, Evaluation, and Treatment of High
Blood Pressure (JNC IV and V) Guidelines have been widely disseminated to
physicians since 1988, supplemented with public education via the National
High Blood Pressure Education Program. To determine the extent to which
these guidelines were implemented in a high fisk population of families with
premature CHD, we examined the prevalence of hypertension (HTN) and
JACC February1997 ABSTRACTS-Poster 49A
associated CHD risk factors (RF) in asymptomatic siblings of persons with
documented premature CHD (<60 years of age). Using the JNCVguidelines,
fJ09siblings (52% male, 17%African American) were classified into treatment
cstegorfes. The prevalence of HTN (2140/90 mmHg, defined by an average
of three resting measures using AHA guidelines) was 38%: half of these
hypertensive siblings met criteria for nonpharmacologic intervention, and the
other half for drug treatment. Among those requiring treatment according
to JNC V, only 56Y0 were aware that they had HTN. This is extremely
important, given the high prevalence of other CHD RF among those eligible
for treatment: 73% were hypercholesterolemic (LDL ? 130 mg/dl); 59% were
obese, aooording to NCHS atandards; 27% were current smokers; and 85%
were consuming more than 30% of calories from fat. Of those eligible for
drug treatment, only 41% were on antihyperfensives, the majority of which
were diuretics. These findings indicate a markedly high prevalence of HTN
wmbined with iow awareness and treatment levels, which particularly in
the presence of mdtlphRF, demonstrate the need for moreaggressive
screening and treatment in this high-risk population.
El952154 Hyperinsullnemia,OverweightandHighBloodPressureIn YoungAdults-The RiodeJaneiro
Study
R. Pozzen, S.L.D. Silva, A.A. BrandFro,A.P. Brandao. L)eptot
Cardiology-StateUniversityof RiodeJaneiro,13rasil
We analyzed the relationship of hyperinsulinemia and overweight in young
adufts (17-23 Yrs) with different percentiles of blood pressure. We evaluata
3906 children and adolescents (10-15 yrs) In their schools in ordar to deter-
mine blood pressure (BP) cuwes. 64 individuals out of these population were
accompanied throughout 8 years in four consecutive screening and stratified
in 3 groups according to the tracking of BP: Group 1 (n = 23, 12 malas) with
BP ? 95th percentile in at least 3 out of 4 evaluations; Group 2 (n = 28, 13
males) with BPs 50’0 percentile Inat least 3 out of 4 screenings and Group 3
(n= 13,3 males) without stable BP percentile. All 64 subjects were submitted
to an oral glucose tolerance test with 75 g of dextrosol, after 12 hours fasting.
Blood samples were collected at O, 30, 60, 90 and 120 minutes for insulin
and glucose measurements. Ovenveight was defined as a body mass index
(BMI) z 25 k@m2:BI ? 30 &lU/ml was considered abnormal, peak value
of insulin (PVI) and gkrmse (PVG) were defined as the highest value after
stimulus and WHO’s criteriou$ were used to identify individuals with glucose
Intolerance (Gl). BMI, systolic (SBP) and diastolic blood pressure (DBP)
were also used for comparison and correlation among the groups. The main
results were: 1) There were no age or sex differences among the groups (p >
0.05); 2) Group 1 had greaterBMl(66.8+2.8x 80.8& 1.5 x 59.3 +2.4 p <
0.02), SBP (128.3+ 2.3 x 109.9 + 1.6 x 115.5+ 1.7p < 0.0001) and DBP
(78.6 & 1.5 x 64.9 + 1.6 x 71.8 + 2.4p < 0.0001) than the other groups;
3) Group 1 had graater BI (17.1 + 2.8 x 8.8 + 0.9 x 10.3 + 1.6p < 0.02),
BG (90.9 + 2.3 X 81.6& 1.6 X 81.6 + 2.2p < 0.0005), PVI (153.4& 76.1
x 96.9 + 33.3 x 123.2 + 54.9 p < 0.005) and PVG (141.3 + 21.0 x 121.1
+ 23.2 x 120.0 + 28.2 p < 0.005) than the other groups; 4) Group 1 had
more prevalence of overweight (6.7% x 32.0% O%p < 0.05) and abnormal
values of BI (3.6% x 21.7% x OYOp < 0.05) than the other groups; 5) GI wee
more prevalent in group 1 than in group 2 (13.I’Yo x O%p < 0.05); 6) The
multivariated analysis showed that SBP was significantly correlated with all
insuiin variables, even when BMI was statistically controlled. We concluded
that the association of high blood pressure, high insulin and glucose levels
and body size can be detected early, but the meaning of these findings would
be better explained on longitudinal studies.
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m923135 Cost-EffectivenessAnalysisofan EarlyLisinopril
usein PatientsWithAcuteMyocardialInfarction:
ResultsFromGISSI-3Trial
M.G. Franzosi, A.P. Maggioni, E. Santoro, G. Tognoni for the GISSI-3
Investigators. ktituto MarioNegri,Italy
As cost containment of the health care system has become a priority, clinical
trialsare now more likely to measure cost-effectiveness outcome as well as
medical outcome. GISSI-3 study tested an early (within 24 hours) treatment
of ACE-inhibitor (Iisinopril) for42 days in 19,394 relatively unselected patients
with acute myocardlal infarction. A statistically significant reduction of 6 week
mortality was achieved in Iisinopril allocated patients when compared to
nolisinopril allocated patients [7.5 (SD 3.8) lives saved per 1,000 treated
patients].
We performed a cost-effectiveness analysis in the total population admit-
tedto GISS1-3study,usingdetaontheuseof medical resourcas prospectively
collected during hospitalization. Charges were converted to costs. Effective-
nesswasmeasured in terms of number of additional survivors among patients
assigned to Iisinopril group. Cost-effectiveness ratios were expressed as cost
per premature death avoided.
On the basis of the 6-week survival analysis of GISS,I-3study, the com-
parative cost-effectiveness ratio iorthe use of Iisinopril was 2,300 US dollars
per premature death avoided.
A sensitivity analysis was conducted to examine the effects of varying the
estimated absolute reduction in monality of 7.5 lives saved per 1000 treated
patients) throughout itsconfidence interval (95% Cl: 0.4 to 14,6 lives saved
per 1,000 treated patients). The cost-effectiveness ratios consequently could
vary from 43,300 to 1,2C0US dollars per premature death avoided.
The cost-effectiveness of Iisinopril treatment compares very favorably
with that of other interventions for acute myocardlal infarction,
1923-136] EValuatlonofChestPaininthe EmergencyRoom:
IeThereGenderBias?A PopulationBaeadStudy
inOfmstedCounty,Minnesota
V.L, Rogar, S.E. Gabriel, G.S, Reeder, P.A.Smars, S.L. Kopecky,
K.A. Traverse, A.R, Zinsmeister, M.E. Farkouh. MayoC/inic,ROohestec
MN,USA
The existence of gender bias in the delivery of cardiac care remains con-
troversial, but if it exists, it may occur at the earliest point in the diagnostic
sequence. We reporf herein the results of the first population-based study
examining sex differences in evaluation and outcome after the first emer-
gency room (ER) visit for chest pain (CP). Between 1985 and 1992, 691
Olmsted County residents (433 men, 258 women), were seen in the ER for
CP.Except forage (women older), men and women were similar in baseline
characteristics, type of CP or ECG findings. Adjustment for baseline charac-
teristics and risk sfatus (AHCPR unstable angina guidelines) was pertormed
with multivariate analysis for the 2 endpoints: utilization of procedures and
outcome. The percentages of men and women having procedures within 90
days after ER visit were:
Men Women pvalue*
?3 procedures 17,20/. 11.6”A <0.01
Any Cardiac Diagnostic 81% 65”A <0.005
AnyCardiacTherapeutic 23,6% 14.s% <0.005
Any GI Diagnostic 12% 15.8°A NS
*p valuesareadjustedforfactorsrelatedto proceduraluse.
After a median follow-up of 4.9 years, 200 cardiovascular events (my-
ocardial infarcti, heart failure, cardiac arrest, cardiac death, and stroke)
were recorded. After adjustment, female sex was not associated with time to
first event.
These population-based data indicate that, affera first ERvisit for CP: (1)
utilization of procedures is lower in women (2) despite this, women do not
appear at increased risk for cardiovascular events.
m923137 MarkedReductionsinOutpatient,Inpatient,andTotafMedicalCostswithComprehensive
Work-SitePrimaryPreventionPrograme
R.V.Milani, C.J. Lavie. OchsnerMedica/Institutions,NewOr/eana,LA,USA
Previous studies have demonstrated that a small minority of employees uti-
Iizethe majorityof corporate health costs, which can be reduced by improving
overall risk status. In a pilot work-site project study of 164 participants and
161 nonparticipants, we aee$ssed the effects of a comprehensive risk as-
sessment and modification program (RAMP) on overall outpatient, inpatient,
and total (inpatient, outpatient, emergency room, and pharmacy) annualized
medical costs before and after a 6 month intervention program. At baseline,
42 (26%) were classified as “high-risk” by anthropometric measurements,
lipids, smoking and blood pressure status, as well as overall health habits
and behavioral data. Following RAMP, high-risk patients markedly improved
their overall health risk score by 40% (p c 0,01), 57?&of whom achieved
low-risk status, Furthermore, low-risk participants improved thair mean total
health score by 10% (p < 0.001). Following RAMP,outpatient medical costs
fell by 35% (p c 0.01) in participants compared to a 16% increase (p <
0.05) in nonparticipants (p <0.01 between groups). In addition, inpatient
costs fell by 73% (p < 0.001) in participants compared with 60% (p < 0.001)
in nonparticipants, resulting in a total reduction in medical costs of 48%
